Share on StockTwits

Targeted Medical Pharma (NASDAQ:TRGM) CEO William Shell sold 3,000 shares of Targeted Medical Pharma stock on the open market in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $0.65, for a total transaction of $1,950.00. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Shares of Targeted Medical Pharma (NASDAQ:TRGM) opened at 0.60 on Wednesday. Targeted Medical Pharma has a 52 week low of $0.49 and a 52 week high of $1.98. The stock’s 50-day moving average is $0.72 and its 200-day moving average is $0.79. The company’s market cap is $15.9 million.

Targeted Medical Pharma Inc is a pharmaceutical company. The Company develops and commercializes nutrient- and pharmaceutical-based therapeutic systems.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.